Interact

This was a pretty cool question from @jeopardy last night.

Check out our NEW Review from Stefan Pfister @DKFZ & colleagues on paediatric solid tumours - the therapeutic vulnerabilities that can be targeted & the available preclinical models to test drug efficacy with a view to accelerate translation @NatResCancer
https://t.co/b9kA3wCcDE

Print version of our recent paper is out today. More work to do! We need easier paths to getting new treatment candidates like these all the way to our patients. @DFBC_PedCare @ncats_nih_gov @StBaldricks @RallyFoundation @PCRF_Kids https://t.co/F1oyLvMQv7 https://t.co/74oojtY0rE

We’re seeking applications from patient-led 501(c)(3) organizations to collaborate with clinicians and researchers to drive progress against their rare diseases https://t.co/DanqT6K43H #RareAsOne

More proof NYC is the best city in the world. Blackout hits, @hadestown takes the show to the sidewalk. (Via @misskimizzo)